Snowball logo
logo
KYNB

Kyntra Bio, Inc.

KYNB β€’ NASDAQ
$4.50$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
235.3140.746.829.626.444.617
COGS
449.220.283.96215.560.5563.779
Gross Profit
(213.9)120.542.8414.065.8840.838
Operating Expenses & Income
Operating Income
(288.5)(301)(322.7)(150.4)(45.9)(50.83)
Total Operating Expenses
74.65421.5365.6164.551.7851.67
R&D Expenses
387296.8266.595.6923.5222.86
Selling General & Admin Expenses
123.9124.786.4849.3327.7127.67
Earnings from Continuing Operations
Interest Expense
(1.075)(1.44)(8.095)(8.247)(8.759)(9.288)
Interest Income
-7.5967.5945.2962.9434.334
Income Tax Expense
0.3470.358(0.252)(0.269)(0.09)(0.324)
Net Income
Net Income
(290)(293.7)(284.2)(47.58)183.5183.2
Supplemental
EBIT
(348.5)(293.4)(315.1)(145.1)(58.29)-
EBITDA
(333.7)(282.8)(305.2)(142.4)(57.55)(94.01)
In millions of USD, except % and values per 1 share